Matches in Nanopublications for { ?s ?p "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP793302.RApj0RCQKYdll3rL4JZjwKJfenHu0m3vro_RA2MjWg0-Y130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793302.RApj0RCQKYdll3rL4JZjwKJfenHu0m3vro_RA2MjWg0-Y130_provenance.
- NP278243.RA4d0-G8jRHDhF6BGni_5xPbEs63UVhzAjY6k13BIFmjQ130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278243.RA4d0-G8jRHDhF6BGni_5xPbEs63UVhzAjY6k13BIFmjQ130_provenance.
- assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605016.RAJP2zakKHizP92edqPInfYr_FvY3kcGT5mlKJsHaWoDk130_provenance.
- NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838374.RATzmMUYPRx-dI48pjiEUd5VkixXtr5v4Gk_9lUYn-tOA130_provenance.
- NP412093.RAKay12SsomR0BhKuf4idoP0gqQyy0KdZrz078iIoBIO8130_assertion description "[Inhibitors of the mammalian target of rapamycin (mTOR) are emerging as promising therapies for metastatic renal cell carcinoma (RCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412093.RAKay12SsomR0BhKuf4idoP0gqQyy0KdZrz078iIoBIO8130_provenance.